Gemcitabine-induced renal thrombotic microangiopathy

Nephrology (Carlton). 2022 Aug;27(8):724-725. doi: 10.1111/nep.14043. Epub 2022 Apr 15.

Authors

Taro Horino¹, Satoshi Inotani¹, Masayuki Ishihara², Yoshio Terada¹

Affiliations

¹ Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi, Japan.
² Department of Paediatrics, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi, Japan.

PMID: 35429056
DOI: 10.1111/nep.14043

No abstract available

Keywords: acute kidney injury; cutaneous T-cell lymphoma; gemcitabine; nephrotic syndrome; thrombotic microangiopathy.

Publication types

Letter

MeSH terms

Deoxycytidine / adverse effects
Deoxycytidine / analogs & derivatives
Gemcitabine
Humans
Kidney
Thrombotic Microangiopathies* / chemically induced
Thrombotic Microangiopathies* / diagnosis

Substances

Deoxycytidine
Gemcitabine